Tau聚集抑制剂提交MAA，有望成为首款AD口服靶向药
UK Personalised ads report 2025
公司简评报告：自主新能源销量表现亮眼，阿维塔首批搭载华为ADS 3.0
整体业绩显著改善，AD系列诊断产品有望迎来商业化
2021年中国阿尔兹海默症（AD）诊断行业概览
Gender & Age Diversity in Global Ad Creative 2019 - 2022
–Game business weighed on revenue growth despite resilient ad and VAS business
医药行业点评：AD药物研发进展迅速，关注AD相关产业链
医药行业周报：AD药物取得突破，看好医药消费和科技崛起
Sri Lanka: Technical Assistance Report-Repeal of Simplified Value Added Tax and the Transition to Risk-Based Value Added Tax Refund Processing
公众号
小程序
社群